Reforma da Lei de patentes na Ucrânia em evidência após sociedade civil pressionar por acesso a medicamentos 09/08/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Parlamentares ucranianos podem aprovar a qualquer momento mudanças importantes na legislação de patentes no país. Em grande parte, as mudanças são motivadas por pressões de grupos de pacientes, que reivindicam melhor acesso a medicamentos e cuidados de saúde.
La société civile au cœur de la mise en œuvre des flexibilités de l’Accord sur les ADPIC 09/08/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Dès son adoption par l’Organisation mondiale du commerce, l’Accord sur les aspects des droits de propriété intellectuelle qui touchent au commerce (ADPIC) prévoyait des flexibilités visant principalement à laisser une marge de manœuvre aux pays en développement, pour que ces derniers puissent mettre en œuvre ses dispositions en tenant compte d’aspects liés au développement. Cependant, certains pays n’ont pas pleinement fait usage de ces flexibilités en raison d’un manque de sensibilisation ou de pressions économiques, et ont connu des difficultés pour répondre à leurs besoins en matière de santé publique. Pour certains, ces difficultés sont justement liées au fait de ne pas avoir utilisé ces flexibilités. La société civile a participé de manière conséquente aux efforts visant à contrer les pressions exercées et à sensibiliser les responsables politiques pour un meilleur accès aux médicaments.
A Look At Honduras’ Appeal In WTO Ruling On Tobacco Plain Packaging 03/08/2018 by David Branigan, Intellectual Property Watch 3 Comments In an appeal of a recent World Trade Organization dispute panel ruling, Honduras detailed a list of alternate interpretations of the decision to uphold Australia’s tobacco plain packaging measures. Honduras called on the WTO Appellate Body to “reverse the Panel’s findings and conclusions,” claiming that the ruling was “not the result of an objective assessment of the matter.”
Counter-Measures – How Startups Can Fight Pirates Without Burning Cash 03/08/2018 by Guest contributor for Intellectual Property Watch Leave a Comment Patent litigation can drain capital during the crucial first few months of launching new technology, a particular problem in the capital-intensive hardware space. Companies need to find creative ways to go after patent thieves without stifling growth or ceding market share, writes Michael A. Nicolas.
Updated WIPO Guide On Alternative Dispute Resolution A Tool For IP Offices 31/07/2018 by Gaensly Joseph for Intellectual Property Watch 2 Comments The World Intellectual Property Organization Arbitration and Mediation Center has released an updated guide providing an overview of alternative dispute resolution (ADR) processes for intellectual property disputes. The guide provides instructions on how to use the ADR process that has helped resolve tens of thousands of legal disputes outside of the courts.
Negotiations On UN Tuberculosis Declaration Still Open, Reports Say 27/07/2018 by William New, Intellectual Property Watch 2 Comments Negotiations for a United Nations declaration on ending tuberculosis had drawn to a close earlier this week, with the United States seeming to succeed on a hardline position to keep mention of intellectual property rights and affordability of medicines out of the text. But nongovernmental reports say the draft has not been accepted by all members and that negotiations will have to be reopened.
AbbVie Hepatitis C Treatment Patents Challenged In India For Evergreening 26/07/2018 by Intellectual Property Watch 1 Comment The Initiative for Medicines, Access & Knowledge (I-MAK) and the Delhi Network of Positive People (DNP+) filed an opposition with the Indian Patent Office in Delhi on 21 July to prevent the granting of a patent to AbbVie on pibrentasvir, which forms part of Mavyret, their drug used to treat Hepatitis C, according to a press release.
UN Political Declaration On TB Finalised: No Commitment To TRIPS Flexibilities 24/07/2018 by David Branigan, Intellectual Property Watch 3 Comments Members of the United Nations concluded negotiations on the draft of the Political Declaration on the Fight Against Tuberculosis on 20 July. After weeks of heated negotiations over the inclusion of references to TRIPS flexibilities in the operative paragraphs, with the Group of 77 pushing for inclusion and the United States against it, the final text of the political declaration reflects the deadlock of these positions. Due to the inability of member states to reach agreement, the final text does not include substantive reference to TRIPS flexibilities. If no countries object, this final draft of the Political Declaration on TB will be adopted by the General Assembly at the High-Level Meeting on Tuberculosis, which will take place on 26 September at the United Nations in New York, and will serve as the authoritative agreement from which action plans will be drawn. According to sources, countries have until tonight in New York to decide whether to object, and G77 nations are considering their options.
South Africa’s Proposed Copyright Fair Use Right Should Be A Model For The World 24/07/2018 by Intellectual Property Watch 3 Comments Copyright laws the world over are under massive pressure to reform to fit the digital environment. One key area often in need of reform is in the exceptions to copyright that enable the digital practices. Without exceptions, common practices may be illegal, such as sharing photos on social media, making technical copies to send and stream, and uploading excerpts to closed networks for student access, writes a group of experts on the issue.
Oppositions Filed Against Gilead Hepatitis C Patent Applications In India 20/07/2018 by Gaensly Joseph for Intellectual Property Watch 2 Comments Oppositions have been filed in India against two patent applications from US pharmaceutical company Gilead for important hepatitis C medicines, according to non-governmental sources. The opposition filings assert that these applications are “evergreening” patents and therefore violate Indian patent law.